Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,718.00
Bid: 2,718.00
Ask: 2,720.00
Change: -24.00 (-0.88%)
Spread: 2.00 (0.074%)
Open: 2,746.00
High: 2,754.00
Low: 2,714.00
Prev. Close: 2,742.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Base Prospectus

18 Sep 2014 15:49

RNS Number : 0685S
Coca-Cola HBC AG
18 September 2014
 



 

FOR IMMEDIATE RELEASE

 

 

 

Coca-Cola HBC AG

Publication of Base Prospectus

 

Zug, Switzerland - 18 September 2014 -Coca-Cola HBC AG ("Coca-Cola HBC") today announces that the base prospectus dated 18 September 2014 in respect of the update of the €3,000,000,000 Euro Medium-Term Note Programme by Coca-Cola HBC Finance B.V. as Issuer and guaranteed by Coca-Cola HBC and Coca-Cola HBC Holdings B.V. (the "Base Prospectus"), originally established on 3 June 2013, has been approved by the UK Listing Authority.

 

To view the Base Prospectus, please paste the following URL into the address bar of your browser.

 

http://www.coca-colahellenic.com/investorrelations/Debtholders/Fundingsources/

 

The Base Prospectus has also been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.

 

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement.

This announcement shall not constitute an offer to sell or a solicitation of an offer to buy the notes or any other securities. The notes under this Euro Medium Term Note Programme will not be registered under the United States Securities Act of 1933 (as amended) and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to or for the account or benefit of U.S. persons.

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +41 41 726 0143

 basak.kotler@cchellenic.com

Eri Tziveli

Investor Relations Manager

Tel: +30 210 618 3133

 eri.tziveli@cchellenic.com

 

Dimitris Bakas

Investor Relations Manager

Tel: +30 210 618 3124

 dimitris.bakas@cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is the second-largest bottler of the brands of The Coca-Cola Company in terms of volume with sales of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 585 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). Coca-Cola HBC is included in the Dow Jones Sustainability and FTSE4Good Indexes. For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBSGDCRSBBGSI
Date   Source Headline
19th Sep 20231:02 pmRNSDirector/PDMR Shareholding
14th Sep 20232:04 pmRNSDirector/PDMR Shareholding
1st Sep 202312:14 pmRNSDirector/PDMR Shareholding
1st Sep 202311:51 amRNSDirector/PDMR Shareholding
18th Aug 202312:16 pmRNSDirector/PDMR Shareholding
18th Jul 20231:06 pmRNSDirector/PDMR Shareholding
11th Jul 20233:53 pmRNSNotice of Results
7th Jul 20237:00 amRNSTRADING UPDATE
3rd Jul 20239:12 amRNSDirector/PDMR Shareholding
3rd Jul 20238:32 amRNSIssue of equity and total voting rights
23rd Jun 20234:04 pmRNSDirector/PDMR Shareholding
21st Jun 202311:05 amRNSDirector/PDMR Shareholding
21st Jun 202310:46 amRNSDirector/PDMR Shareholding
19th Jun 20233:06 pmRNSDirector/PDMR Shareholding
19th Jun 20237:00 amRNSCCH to acquire Finlandia Vodka from Brown-Forman
1st Jun 202310:07 amRNSIssue of equity and total voting rights
25th May 20237:00 amRNSCoca-Cola HBC Investor Day
18th May 20232:50 pmRNSDirector/PDMR Shareholding
18th May 20232:46 pmRNSDirector/PDMR Shareholding
17th May 20233:44 pmRNSCCH - Board Committees Composition
17th May 20233:37 pmRNSResult of AGM
4th May 20232:43 pmRNSAthens Exchange trading date of ordinary shares
3rd May 20237:00 amRNSStrategic progress driving strong revenue growth
2nd May 202311:23 amRNSBlock listing Interim Review
2nd May 202310:38 amRNSIssue of equity and total voting rights
24th Apr 20232:03 pmRNSNotice of Results-NEW TIME for the analysts call
18th Apr 20232:46 pmRNSDirector/PDMR Shareholding
13th Apr 20238:41 amRNSNotice of AGM
3rd Apr 20233:14 pmRNSNotice of Results
3rd Apr 20232:52 pmRNSIssue of equity and total voting rights
31st Mar 20232:54 pmRNSDirector/PDMR Shareholding
31st Mar 202312:30 pmRNSDirector/PDMR Shareholding
31st Mar 202312:22 pmRNSDirector/PDMR Shareholding
31st Mar 20239:11 amRNSDirector/PDMR Shareholding
31st Mar 20238:52 amRNSDirector/PDMR Shareholding
24th Mar 20231:48 pmRNSDirector/PDMR Shareholding
23rd Mar 20231:10 pmRNSDirector/PDMR Shareholding
21st Mar 20239:48 amRNSDirector/PDMR Shareholding
21st Mar 20239:20 amRNSDirector/PDMR Shareholding
20th Mar 20234:11 pmRNSAnnual Financial Report
17th Mar 20232:39 pmRNSDirector/PDMR Shareholding
15th Mar 20232:38 pmRNSDirector/PDMR Shareholding
8th Mar 202310:46 amRNSHolding(s) in Company
7th Mar 202311:56 amRNSHolding(s) in Company
6th Mar 20233:29 pmRNSDirector/PDMR Shareholding
3rd Mar 20238:00 amRNSDirector/PDMR Shareholding
1st Mar 20232:11 pmRNSIssue of equity and total voting rights
28th Feb 20238:09 amRNSDirector/PDMR Shareholding
23rd Feb 20239:21 amRNSDirector/PDMR Shareholding
22nd Feb 20233:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.